A Phase 1a/1b Study of ACTM-838 in Patients With Advanced Solid Tumors
Actym Therapeutics, Inc.
Actym Therapeutics, Inc.
Elicio Therapeutics
University Hospital, Ghent
Pfizer
Carisma Therapeutics Inc
UTC Therapeutics Inc.
Celldex Therapeutics
Xencor, Inc.
MacroGenics
Karolinska University Hospital
Abramson Cancer Center at Penn Medicine
City of Hope Medical Center
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Duke University
National Cancer Institute (NCI)
National Institutes of Health Clinical Center (CC)
National Cancer Institute (NCI)
NYU Langone Health